Company profile

NYSE: ROG

ROGERS CORP

ROGERS CORP (ROG) is a U.S. SEC registrant. The Commission classifies the issuer under SIC 2821 (Plastic Materials, Synth Resins & Nonvulcan Elastomers).

CIK
0000084748
Research Profile
Developing · 79
Coverage
Universe
Profile updated
Sep 9, 2026
Business
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Exchange / ticker
NYSE: ROG
Industry
Healthcare
Headquarters
United States
Latest revenue
$200.5M
Latest filing
10-Q · Jul 29, 2026
Coverage status
Universe only
Taxonomy
US-GAAP

Company overview

What does ROGERS CORP do?

ROGERS CORP (ROG) is a U.S. SEC registrant. The Commission classifies the issuer under SIC 2821 (Plastic Materials, Synth Resins & Nonvulcan Elastomers).

What does ROGERS CORP do?

ROGERS CORP (ROG) is a U.S. SEC registrant. The Commission classifies the issuer under SIC 2821 (Plastic Materials, Synth Resins & Nonvulcan Elastomers).

What industry is ROGERS CORP in?

Healthcare · Plastic Materials, Synth Resins & Nonvulcan Elastomers

What was ROGERS CORP's latest reported revenue?

$200.5M for Q1 2026, from 10-Q filed Apr 29, 2026.

What changed in the latest comparable period?

Revenue increased +5.2% ($190.5M to $200.5M; Q1 2025 vs Q1 2026).

Business model (from the public record)

Belvedere describes the business using the issuer’s SEC classification and the company description extracted from public filings. Segment mix, customer identity, and recurring-versus-transactional revenue are shown only when those facts are identified in the filing extract—not inferred.

Healthcare · Plastic Materials, Synth Resins & Nonvulcan Elastomers · United States

Financial profile

Revenue
$200.5M
10-Q · Q1 2026 · Filed Apr 29, 2026
Revenue growth YoY
+5.2%
Belvedere calculation · 10-Q · Q1 2026 · Filed Apr 29, 2026
Gross margin
+32.2%
Belvedere calculation · 10-Q · Q1 2026 · Filed Apr 29, 2026
Operating margin
+5.3%
Belvedere calculation · 10-Q · Q1 2026 · Filed Apr 29, 2026
Net income
$4.5M
10-Q · Q1 2026 · Filed Apr 29, 2026
Operating cash flow
$5.8M
10-Q · Q1 2026 · Filed Apr 29, 2026
Capex
$4.7M
10-Q · Q1 2026 · Filed Apr 29, 2026
Belvedere FCF
$1.1M
Belvedere calculation · 10-Q · Q1 2026 · Filed Apr 29, 2026
FCF margin
+0.5%
Belvedere calculation · 10-Q · Q1 2026 · Filed Apr 29, 2026
Cash
$195.8M
10-Q · Mar 31, 2026 · Filed Apr 29, 2026
Debt
Not identified in latest matched XBRL period
Net debt
-$195.8M
Belvedere calculation · 10-Q · Mar 31, 2026 · Filed Apr 29, 2026
Shares
17,800,000
10-Q · Mar 31, 2026 · Filed Apr 29, 2026

Balance sheet snapshot

Cash $195.8M. Identified debt . Net debt -$195.8M. Missing debt tags are not treated as a zero-debt capital structure.

Financial information is derived from public filings and other identified sources. Belvedere calculations may differ from company-defined non-GAAP measures. See methodology and source notes. Valuation multiples are omitted because a licensed market-data provider is not configured.

Latest filings

FormFiledPeriodAccessionSource
10-QJul 29, 2026Jun 30, 20260000084748-26-000048SEC
8-KJul 28, 2026Jul 28, 20260000084748-26-000046SEC
8-KMay 19, 2026May 19, 20260000084748-26-000036SEC
8-KMay 7, 2026May 6, 20260000084748-26-000028SEC
10-QApr 29, 2026Mar 31, 20260000084748-26-000023SEC
8-KApr 28, 2026Apr 28, 20260000084748-26-000022SEC
DEF 14AMar 24, 2026May 6, 20260001140361-26-010927SEC
8-KMar 3, 2026Mar 2, 20260000084748-26-000010SEC

What changed

Revenue+5.2%Revenue increased +5.2% ($190.5M to $200.5M; Q1 2025 vs Q1 2026).
Gross margin$0.32Reported gross margin was +32.2% in the latest comparable period.
Operating cash flow$5.8MNet cash provided by operating activities was $5.8M.
Cash$195.8MCash and cash equivalents were $195.8M as of the latest reported balance-sheet date.
Shares outstanding$17.8MShares outstanding were 17,800,000 as of the latest reported date.

Each line is an arithmetic comparison of sourced facts. It is not a thesis.

Research view

Belvedere has not published an initiation or update on ROGERS CORP. Universe inclusion is not a rating, a forecast, or coverage in the sell-side sense.

Research Radar

KindChangeExplanationSourceDate
Revenue+5.2%Revenue increased +5.2% ($190.5M to $200.5M; Q1 2025 vs Q1 2026).10-Q · RevenueFromContractWithCustomerExcludingAssessedTaxApr 29, 2026
Margin change$0.322Reported gross margin was +32.2% in the latest comparable period.10-Q · BelvedereGrossMarginApr 29, 2026
Cash generation$5.8MNet cash provided by operating activities was $5.8M.10-Q · NetCashProvidedByUsedInOperatingActivitiesApr 29, 2026
Cash$195.8MCash and cash equivalents were $195.8M as of the latest reported balance-sheet date.10-Q · CashAndCashEquivalentsAtCarryingValueApr 29, 2026
Share count$17.8MShares outstanding were 17,800,000 as of the latest reported date.10-Q · CommonStockSharesOutstandingApr 29, 2026

Open the full Research Radar

Rankings

Industry context

ROGERS CORP is mapped to Healthcare (Plastic Materials, Synth Resins & Nonvulcan Elastomers) from SIC metadata on the SEC submission. Mapping is a classification convenience, not a claim that every peer is economically comparable.

Belvedere Research Profile

DevelopingResearch Profile Index 79

This measures researchable information characteristics. It is not investment advice, a credit rating, or a buy/sell/hold recommendation.

Financial Disclosure87

Presence of core income-statement, cash-flow and balance-sheet concepts in SEC XBRL.

Operating Visibility100

Comparable-period revenue history and operating-result availability.

KPI Transparency100

Availability of margin, cash-flow and per-share concepts used in screening.

Investor Information60

SEC periodic reports, current reports, proxy statement and website identified in submissions.

Financial History47

Distinct filing years in the current archive window plus comparable prior-period revenue.

Research Profile methodology

Risks

Belvedere does not manufacture generic risk language. Material risks are those the issuer discloses in its periodic reports, particularly Item 1A of the latest Form 10-K.

A Form 10-K was not present in the current filing window.

Sources

Revenue: $200.5M
Source
U.S. Securities and Exchange Commission
Form
10-Q
Period
Q1 2026
Filed
Apr 29, 2026
Accession
0000084748-26-000023
Concept
RevenueFromContractWithCustomerExcludingAssessedTax
View filing
Revenue growth (Belvedere calculation)
Source
U.S. Securities and Exchange Commission
Form
10-Q
Period
Q1 2026
Filed
Apr 29, 2026
Accession
0000084748-26-000023
Concept
BelvedereRevenueGrowthYoY

(RevenueFromContractWithCustomerExcludingAssessedTax 2026-03-31 / RevenueFromContractWithCustomerExcludingAssessedTax 2025-03-31) - 1

View filing
Free cash flow (Belvedere calculation)
Source
U.S. Securities and Exchange Commission
Form
10-Q
Period
Q1 2026
Filed
Apr 29, 2026
Accession
0000084748-26-000023
Concept
BelvedereFreeCashFlow

Net cash provided by operating activities − payments to acquire property, plant and equipment

View filing
Cash
Source
U.S. Securities and Exchange Commission
Form
10-Q
Period
Mar 31, 2026
Filed
Apr 29, 2026
Accession
0000084748-26-000023
Concept
CashAndCashEquivalentsAtCarryingValue
View filing

Disclosure

Belvedere Research publishes informational analysis. Nothing on this site is investment advice, an offer, or a solicitation to buy or sell any security.

This page is a company intelligence / data profile. It is not a research report unless a dated note is attached above. Rankings appearing here are independent of any issuer compensation.

Frequently asked questions

What does ROGERS CORP do?
ROGERS CORP (ROG) is a U.S. SEC registrant. The Commission classifies the issuer under SIC 2821 (Plastic Materials, Synth Resins & Nonvulcan Elastomers).
What industry is ROGERS CORP in?
ROGERS CORP is classified in Healthcare (Plastic Materials, Synth Resins & Nonvulcan Elastomers).
When did ROGERS CORP last file a periodic report?
ROGERS CORP last filed a 10-Q on Jul 29, 2026 (accession 0000084748-26-000048).
What was ROGERS CORP's latest revenue?
$200.5M for Q1 2026, sourced from 10-Q filed Apr 29, 2026.
Does Belvedere cover ROGERS CORP?
ROGERS CORP is in the Belvedere universe. Presence in the universe is not the same as active initiation coverage.